NBS stock price is on the rise again after NeoStem Inc. (NYSE MKT: NBS) was upgraded by analysts at WBB Securities from a “buy” to a “strong-buy“. The stem cell stock appears to be closing in on its 9th positive trading session ot of the ...
Continue Reading →
9
JUL
JUL
0
Share